Synopsis
Synopsis
0
CEP/COS
0
KDMF
0
VMF
0
Canada
0
Australia
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. Bromide, Vecuronium
2. Citrate, Vecuronium
3. Hydrobromide, Vecuronium
4. Hydrochloride, Vecuronium
5. Maleate, Vecuronium
6. Nc 45
7. Nc-45
8. Nc45
9. Norcuron
10. Org Nc 45
11. Org Nc45
12. Org-nc 45
13. Org-nc-45
14. Org-nc45
15. Orgnc 45
16. Orgnc45
17. Phosphate, Vecuronium
18. Vecuronium
19. Vecuronium Bromide, Quaternary Ion
20. Vecuronium Citrate
21. Vecuronium Hydrobromide
22. Vecuronium Hydrochloride
23. Vecuronium Maleate
24. Vecuronium Phosphate
1. 50700-72-6
2. Norcuron
3. Org Nc 45
4. Vecuronii Bromidum
5. Bromuro De Vecuronio
6. Vecuronium (bromide)
7. Bromure De Vecuronium
8. Org-nc 45
9. 7e4php5n1d
10. Acetate;bromide
11. Chebi:9940
12. Musculax
13. Nsc-759184
14. 1-(3alpha,17beta-dihydroxy-2beta-piperidino-5alpha-androstan-16beta,5alpha-yl)-1-methylpiperidinium Bromide, Diacetate
15. Dsstox_cid_3736
16. (+)-1-(3,17-diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium Bromide
17. Dsstox_rid_77174
18. Dsstox_gsid_23736
19. [(2s,3s,10s,13s,16s,17r)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] Acetate;bromide
20. [(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl] Acetate;bromide
21. Nc-45
22. 1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide Hydrate
23. Cas-50700-72-6
24. Vecuronii Bromidum [inn-latin]
25. Ncgc00167467-01
26. Bromure De Vecuronium [inn-french]
27. Bromuro De Vecuronio [inn-spanish]
28. Einecs 256-723-9
29. Unii-7e4php5n1d
30. Vecronium Bromide
31. Norcuron (tn)
32. [(2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-17-acetyloxy-10,13-dimethyl-16-(1-methylpiperidin-1-ium-1-yl)-2-piperidin-1-yl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-3-yl]
33. Mfcd00867762
34. Vecuronium Bromide [usan:usp:inn:ban:jan]
35. 5alpha-androstan-3alpha,17beta-diol, 16beta-pipecolinio-2beta-piperidino-,bromide,diacetate
36. Schembl22250
37. Mls001424317
38. Piperidinium, 1-((2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl)-1-methyl-, Bromide
39. Vecuronium Bromide [mi]
40. Chembl1200629
41. Dtxsid1023736
42. Vecuronium Bromide [inn]
43. Vecuronium Bromide [jan]
44. Hy-b0118a
45. Vecuronium For System Suitability
46. Vecuronium Bromide [usan]
47. Hms2052i21
48. Hms3715l15
49. Hms3884c15
50. Vecuronium Bromide [vandf]
51. Vecuronium Bromide [mart.]
52. 1-[(1s,2s,4s,5s,7s,10r,11s,13s,14r,15s)-5,14-bis(acetyloxy)-2,15-dimethyl-4-(piperidin-1-yl)tetracyclo[8.7.0.0^{2,7}.0^{11,15}]heptadecan-13-yl]-1-methylpiperidin-1-ium Bromide
53. Bcp06528
54. Vecuronium Bromide (jan/usp/inn)
55. Vecuronium Bromide [usp-rs]
56. Vecuronium Bromide [who-dd]
57. Tox21_112471
58. Akos005145904
59. Akos007930694
60. Tox21_112471_1
61. Ac-2000
62. Ccg-101147
63. Cs-1881
64. Nc00397
65. Nsc 759184
66. Vecuronium Bromide [ep Impurity]
67. Vecuronium Bromide [orange Book]
68. Ncgc00167467-03
69. Vecuronium Bromide [ep Monograph]
70. 1-((2s,3s,5s,8r,9s,10s,13s,14s,16s,17r)-3,17-diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1h-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium Bromide
71. Ds-12625
72. Piperidinium, 1-(3-alpha,17-beta-diacetoxy-2-beta-piperidino-5-alpha-androstan-16-beta-yl)-1-methyl-, Bromide
73. Smr000471625
74. Vecuronium Bromide [usp Monograph]
75. S1405
76. V0120
77. D00767
78. Pancuronium Bromide Impurity, Vecuronium Bromide -
79. Sr-01000763634
80. Pancuronium Bromide Impurity D [ep Impurity]
81. Q-101014
82. Sr-01000763634-3
83. Q27108523
84. Z1551429734
85. Vecuronium Bromide, European Pharmacopoeia (ep) Reference Standard
86. Pancuronium Bromide Impurity, Vecuronium Bromide - [usp Impurity]
87. Vecuronium Bromide, United States Pharmacopeia (usp) Reference Standard
88. 1-(3,17-diacetoxy-2-piperidino-5-androstan-16-yl)-1-methylpiperidinium Bromide
89. Vecuronium Bromide, Pharmaceutical Secondary Standard; Certified Reference Material
90. Vecuronium For Peak Identification, European Pharmacopoeia (ep) Reference Standard
91. Vecuronium For System Suitability, European Pharmacopoeia (ep) Reference Standard
92. (2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane Bromide
93. (2beta,3alpha,5alpha,16beta,17beta)-3,17-diacetoxy-16-(1-methylpiperidinium-1-yl)-2-(piperidin-1-yl)androstane Bromide
94. 1-((2s,3s,5s,10s,13s,16s,17r)-3,17-diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1h-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-ium Bromide
95. 1-((2s,3s,5s,10s,13s,16s,17r)-3,17-diacetoxy-10,13-dimethyl-2-(piperidin-1-yl)hexadecahydro-1h-cyclopenta[a]phenanthren-16-yl)-1-methylpiperidin-1-iumbromide
96. 1-(3.alpha.,17.beta.-dihydroxy-2.beta.-piperidino-5.alpha.-androstan-16.beta.,5.alpha.-yl)-1-methylpiperidinium Bromide, Diacetate
97. 1-[(2beta,3alpha,5alpha,16beta,17beta)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl]-1-methylpiperidinium Bromide
98. 1-[3alpha,17beta-bis(acetoxy)-2beta-(1-piperidinyl)-5alpha-androstan-16beta-yl]-1-methylpiperidinium Bromide
99. Piperidinium, 1-((2.beta.,3.alpha.,5.alpha.,16.beta.,17.beta.)-3,17-bis(acetyloxy)-2-(1-piperidinyl)androstan-16-yl)-1-methyl-, Bromide
Molecular Weight | 637.7 g/mol |
---|---|
Molecular Formula | C34H57BrN2O4 |
Hydrogen Bond Donor Count | 0 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 6 |
Exact Mass | 636.35017 g/mol |
Monoisotopic Mass | 636.35017 g/mol |
Topological Polar Surface Area | 55.8 Ų |
Heavy Atom Count | 41 |
Formal Charge | 0 |
Complexity | 958 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Vecuronium bromide |
Drug Label | Vecuronium Bromide for Injection is a nondepolarizing neuromuscular blocking agent of intermediate duration, chemically designated as 1-(3,17-Dihydroxy-2-piperidino-5- androstan-16,5-yl)-1-methylpiperidinium bromide, diacetate. The struct... |
Active Ingredient | Vecuronium bromide |
Dosage Form | Injectable |
Route | Injection |
Strength | 10mg/vial; 20mg/vial |
Market Status | Prescription |
Company | Bedford; Hospira; Teva Pharms Usa; Sun Pharma Global; Mustafa Nevzat; Agila Speclts |
2 of 2 | |
---|---|
Drug Name | Vecuronium bromide |
Drug Label | Vecuronium Bromide for Injection is a nondepolarizing neuromuscular blocking agent of intermediate duration, chemically designated as 1-(3,17-Dihydroxy-2-piperidino-5- androstan-16,5-yl)-1-methylpiperidinium bromide, diacetate. The struct... |
Active Ingredient | Vecuronium bromide |
Dosage Form | Injectable |
Route | Injection |
Strength | 10mg/vial; 20mg/vial |
Market Status | Prescription |
Company | Bedford; Hospira; Teva Pharms Usa; Sun Pharma Global; Mustafa Nevzat; Agila Speclts |
Neuromuscular Nondepolarizing Agents
Drugs that interrupt transmission at the skeletal neuromuscular junction without causing depolarization of the motor end plate. They prevent acetylcholine from triggering muscle contraction and are used as muscle relaxants during electroshock treatments, in convulsive states, and as anesthesia adjuvants. (See all compounds classified as Neuromuscular Nondepolarizing Agents.)
Nicotinic Antagonists
Drugs that bind to nicotinic cholinergic receptors (RECEPTORS, NICOTINIC) and block the actions of acetylcholine or cholinergic agonists. Nicotinic antagonists block synaptic transmission at autonomic ganglia, the skeletal neuromuscular junction, and at central nervous system nicotinic synapses. (See all compounds classified as Nicotinic Antagonists.)
17.4k
11 - 50
52.4
9,10,132.0
API Imports and Exports
Importing Country | Total Quantity (KGS) |
Average Price (USD/KGS) |
Number of Transactions |
---|---|---|---|
INDIA | 39.91 | 16,105.9 | 11 - 50 |
INDIA | 12.19 | 21,330.0 | <10 |
TURKEY | 0.05 | 17,878.0 | <10 |
ARGENTINA | 0.25 | 17,673.6 | <10 |
INDIA | 0.05 | 40,392.0 | <10 |
Upgrade, download data, analyse, strategize, subscribe with us
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?